Hepatitis C virus genotypes in elderly patients with chronic hepatitis C

Area of Science:

• Hepatology
• Virology
• Epidemiology

Background:

• Hepatitis C virus (HCV) genotype and subtype determination is crucial for understanding epidemiological characteristics.
• HCV subtypes serve as prognostic factors for disease severity and interferon (IFN) treatment response in chronic hepatitis C (CHC).
• Limited data exists on HCV genotype prevalence and its clinical implications in elderly CHC patients.

Purpose of the Study:

• To determine HCV genotypes and subtypes in elderly CHC patients (65-75 years) in Eastern Sicily.
• To gather epidemiological data on HCV genotype prevalence in this specific demographic.
• To evaluate the relationship between HCV subtypes, disease severity, and IFN response in elderly patients.

Main Methods:

• Study involved 22 elderly CHC patients (Group A, 65-75 years).
• HCV-RNA subtypes were analyzed and compared with younger cohorts (Group B: 36-64 years; Group C: 20-35 years).
• Prevalence of HCV subtypes was assessed across the age groups.

Main Results:

• HCV-RNA was detected in 20 out of 22 elderly patients (90.9%).
• HCV subtype 1b was the predominant subtype (100%) in the elderly group.
• Other HCV subtypes were more frequent in younger patient groups, particularly in the youngest cohort.

Conclusions:

• HCV subtype 1b appears to be indigenous to Eastern Sicily.
• HCV subtype 1b alone cannot be considered the sole prognostic factor for disease severity or IFN response in elderly CHC patients.
• Further research is needed to understand the complex interplay of HCV genotypes, age, and treatment outcomes.